Partnership Seeks to Improve Lung Cancer Diagnostic Testing

Horizon Diagnostics has signed a strategic partnership agreement with UK NEQAS focussing on the development of genetically defined reference standards for novel lung cancer biomarkers. The reference materials, containing defined allelic ratios will be ...
See all stories on this topic » Tags: agreement, cancer biomarkers, Horizon, horizon diagnostics, NEQAS, Partnership, partnership agreement, reference, strategic partnership, UK, uk neqas

Related Articles

• MGH’s Diagnostic Electron Microscopy Unit Hopes to Improve Effectiveness in …
• Lab21 launches diagnostic testing for lung cancer patients
• New DNA Testing May Improve Lung Cancer Treatment
• Horizon, UK NEQAS Ally to Improve Accuracy of Lung Cancer Diagnostics – Genetic Engineering News
• New Lung Cancer Companion Diagnostic Service Launched by Lab21
• National Lung Cancer Partnership, Medical Centers Collaborate to Provide Tumor … – Albany Times Union
• Best People To Ask About Lung Cancer | Improve Your Health
• Trainworks seeks environmental approval after asbestos removal and water testing
• Development of the Diagnostic System of Lung Cancer | Medical …
• Tips On Choosing Your Mesothelioma Attorney | Improve Your Health